The integrative molecular characterization of synthetic and patient NUP98-KDM5AAMKL samples revealed SELP, MPIG6B, and NEO1 as distinctive and novel disease biomarkers.
NUP98/JARID1A was not an independent prognostic factor for 5-year overall (probability of overall survival (pOS)) or event-free survival (probability of event-free survival (pEFS)), although the 5-year pOS for the entire AMKL cohort was poor (42 ± 6%).